Search by Drug Name or NDC
NDC 24338-0016-14 Adthyza 9.5; 2.25 ug/1; ug/1 Details
Adthyza 9.5; 2.25 ug/1; ug/1
Adthyza is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Azurity Pharmaceuticals, Inc.. The primary component is LEVOTHYROXINE; LIOTHYRONINE.
Product Information
| NDC | 24338-0016 |
|---|---|
| Product ID | 24338-016_91f59ed1-3217-40ca-98bf-25e84ca3902f |
| Associated GPIs | |
| GCN Sequence Number | 063495 |
| GCN Sequence Number Description | thyroid,pork TABLET 16.25 MG ORAL |
| HIC3 | P3A |
| HIC3 Description | THYROID HORMONES |
| GCN | 99221 |
| HICL Sequence Number | 002846 |
| HICL Sequence Number Description | THYROID,PORK |
| Brand/Generic | Generic |
| Proprietary Name | Adthyza |
| Proprietary Name Suffix | thyroid |
| Non-Proprietary Name | Levothyroxine and Liothyronine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 9.5; 2.25 |
| Active Ingredient Units | ug/1; ug/1 |
| Substance Name | LEVOTHYROXINE; LIOTHYRONINE |
| Labeler Name | Azurity Pharmaceuticals, Inc. |
| Pharmaceutical Class | Thyroxine [CS], Triiodothyronine [CS], l-Thyroxine [EPC], l-Triiodothyronine [EPC] |
| DEA Schedule | n/a |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Application Number | n/a |
| Listing Certified Through | 2024-12-31 |
Package
NDC 24338-0016-14 (24338001614)
| NDC Package Code | 24338-016-14 |
|---|---|
| Billing NDC | 24338001614 |
| Package | 14 TABLET in 1 BOTTLE (24338-016-14) |
| Marketing Start Date | 2023-02-20 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |